OA

Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

Retrieved on: 
Thursday, March 28, 2024

Pluri’s patented coffee cell technology uses the Company’s breakthrough 3D cell expansion technology for mass-scale coffee plant cell cultivation.

Key Points: 
  • Pluri’s patented coffee cell technology uses the Company’s breakthrough 3D cell expansion technology for mass-scale coffee plant cell cultivation.
  • The Company is leveraging two decades of experience and know-how in cell manufacturing to drive the future of coffee science.
  • Pluri’s Chief Executive Officer & President Yaky Yanay will participate in a panel of discussions and Chief Business Development Officer of Pharma Efrat Kaduri will attend the event.
  • It demonstrated increased muscle strength in two clinical studies and is believed to induce systemic anti-inflammatory effect and to reduce post-operative oxidative stress.

BioElectronics Corporation Announces the Publication of a Canine Arthritis Study

Retrieved on: 
Monday, March 25, 2024

Forty-nine animals completed the study. No negative side effects were reported. Average subjective discomfort scores for the treatment group (N=26) were reduced from 4.26 to 2.31 (45%) compared to no improvement in the placebo group (N=23) over the study period. Average PROM scores increased by 5.51 (4.59--6.23) degrees relative to the placebo group. Ninety-six percent of the treatment group showed either increased PROM or improved behavioral changes or both compared to 4% for the placebo group. Most changes occurred within the first 8 days of treatment.

Key Points: 
  • The study was published online by Veterinary Medicine & Science, and can be viewed here: https://doi.org/10.1002/vms3.1408
    A randomized, blinded, placebo-controlled 14-day study of 60 dogs having prior veterinary-diagnosis OA in at least one limb joint.
  • BioElectronics’ Model 088 device was secured near the cervical region of the dog’s spine.
  • Osteoarthritis is the most common type of arthritis in dogs and is the most common source of chronic pain in older dogs.
  • Armed with these published results, BioElectronics Corporation will pursue appropriately qualified distribution partners to market and sell its unique pulsed shortwave device into the veterinary medicine market.

A Majority of Grade 9-12 Public Schools Rate Themselves Favorably on Preparing Students for College

Retrieved on: 
Tuesday, March 19, 2024

WASHINGTON, March 19, 2024 /PRNewswire/ -- A majority of public schools offering any of grades 9 or above (9-12 schools) say they do a "good," "very good," or "excellent" job preparing students for college (77 percent) and the workforce (86 percent), according to new data from the National Center for Education Statistics (NCES), the statistical center within the U.S. Department of Education's Institute of Education Sciences (IES). For college preparation, 47 percent of schools overall rated themselves as doing a "very good" or "excellent" job, whereas the percentage was lower for schools in high-poverty neighborhoods and schools with fewer than 300 students (30 percent each), and higher for schools that enroll 1,000 or more students (74 percent).

Key Points: 
  • "This latest report provides valuable insights on how schools rate their own work preparing students for college and the workforce," said NCES Commissioner Peggy G. Carr.
  • "One noteworthy finding is that a lower percentage of schools in high-poverty neighborhoods give themselves the highest marks, 'excellent' or 'very good,' in preparing students for college, when compared with the national population of schools.
  • The new NCES data also provide insights into the availability of advanced coursework in public schools.
  • In addition to data on advanced coursework offerings, this month's collection explored the availability of independent world language courses taught in K-12 public schools.

AnaCredit plausibility checks, version 2.0

Retrieved on: 
Tuesday, April 2, 2024

AnaCredit plausibility

Key Points: 
    • AnaCredit plausibility
      checks
      Plausibility checks performed on
      AnaCredit datasets
      Version 2.0

      March 2024

      Contents
      1

      Introduction

      2

      2

      Plausibility checks

      3

      2.1

      Definitions

      3

      2.2

      Classification

      4

      3

      AnaCredit external plausibility checks

      7

      3.1

      Plausibility checks with other statistical reporting frameworks

      8

      3.2

      Plausibility checks with supervisory reporting frameworks

      AnaCredit plausibility checks ? Contents

      27

      1

      1

      Introduction
      This document sets out the AnaCredit plausibility checks.

    • AnaCredit plausibility checks ? Plausibility checks

      3

      are erroneous and require revision; second, where the AnaCredit data are correct
      but the BSI data have not been reported correctly; third, where methodological
      differences in the requirements of the two datasets justify the discrepancy.

    • Figure 1
      Types of AnaCredit plausibility check
      Structure

      Stability

      per OA

      Consistency within or across attributes

      Time consistency of aggregate metrics

      across OAs

      Consistency with data of other OAs

      Changes in relative position compared
      to other OAs

      Benchmark
      comparisons

      Consistency with statistical and/or
      supervisory reporting

      Consistency of ratios over time

      Internal
      plausibility

      External
      plausibility

      AnaCredit plausibility checks ? Plausibility checks

      4

      2.2.1

      Internal plausibility checks
      Internal plausibility checks are self-contained within the AnaCredit data set, i.e.

    • AnaCredit plausibility checks ? Plausibility checks

      5

      2.2.2

      External plausibility checks
      External plausibility checks assess the consistency of data reported under AnaCredit
      with other datasets.

    • AnaCredit plausibility checks ? Plausibility checks

      6

      3

      AnaCredit external plausibility checks
      The following subsections contain the details of the AnaCredit external plausibility
      checks.

    • List of external plausibility checks performed under AnaCredit
      Table 1 shows the external plausibility checks under AnaCredit.
    • Plausibility checks with other statistical reporting
      frameworks
      This section includes AnaCredit external plausibility checks against other statistical
      reporting frameworks.
    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      9

      3.1.1.2

      ?

      loans to other financial intermediaries, financial auxiliaries, captive financial
      institutions and money lenders (S.125+S.126+S.127) across all maturity
      breakdowns;

      ?

      loans to insurance corporations (S.128) across all maturity breakdowns;

      ?

      loans to pension funds (S.129) across all maturity breakdown.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      10

      instruments (loans), so the resulting aggregate is a good match to the BSI statistic.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      12

      loans.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      14

      If any of the input data necessary for this calculation are missing or inconsistent, the
      [relevant BSI balance] resolves to NULL for the instrument concerned.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      16

      the latter assuming the credit risk and the MFI being responsible for managing the
      loan.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      17

      Intra-company instrument flag
      BSI statistics also include intra-company loans, i.e.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      18

      Settled loans
      BSI statistics only include loans which have been settled, i.e.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      20

      resolves to NULL for the instrument concerned.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      25

      divided by the number of the main debtors.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      26

      3.2

      Plausibility checks with supervisory reporting frameworks
      This section includes AnaCredit external plausibility checks against supervisory
      reporting frameworks.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      27

      FINREP templates and compared with suitably computed AnaCredit equivalents for
      banks reporting the supervisory financial information under Regulation ECB/2015/13
      (FINREP solo).

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      28

      Figure 3
      Calculation flow ? schematic overview of the comparison with FINREP solo

      By stacking the FINREP solo benchmark side-by-side with its AnaCredit equivalent,
      the deviation between the values can be quantified.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      29

      3.2.2.1

      FINREP solo benchmark value
      As mentioned, comparing AnaCredit with supervisory financial information helps
      ensure accounting information on loan portfolios that must be reported to AnaCredit
      is reported properly.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      30

      Table 3
      The formula for the benchmark DP_FNRP_F1800_ALL_00 from data points from the
      reporting templates of the EBA reporting framework.

    • The composition of FINREP solo reporters thus defined serves as a basis for
      determining (i) which AnaCredit observed agents correspond to which FINREP solo
      reporters, and (ii) the extent to which the perimeter of a FINREP solo reporter can be
      reconstructed from AnaCredit (given that some observed agents may have been

      AnaCredit plausibility checks ? AnaCredit external plausibility checks

      32

      derogated from reporting to AnaCredit).

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      34

      For a given FINREP solo reporter, the result of the calculation described in this
      section (i.e.

    • AnaCredit plausibility checks ? AnaCredit external plausibility checks

      35

      ? European Central Bank, 2024
      Postal address
      Telephone
      Website

      60640 Frankfurt am Main, Germany
      +49 69 1344 0
      www.ecb.europa.eu

      All rights reserved.

Fortanix Brings Industry-Leading Data Security Solutions to Help Japanese Enterprises Prevent Data Breaches and Protect Sensitive Data

Retrieved on: 
Thursday, March 7, 2024

The company will exhibit its hybrid, multi-cloud data security capabilities at Security Days Spring 2024, which takes place March 12-15 in Tokyo.

Key Points: 
  • The company will exhibit its hybrid, multi-cloud data security capabilities at Security Days Spring 2024, which takes place March 12-15 in Tokyo.
  • “Japan is one of the top economies in the world, with many leading enterprises across industries that demand the highest level of data security,” said Anand Kashyap , CEO and co-founder of Fortanix.
  • “By implementing Fortanix DSM, we were able to secure data in SaaS applications such as Fortanix partner DreamArts' SmartDB.
  • Specifically, Fortanix will provide demos of its Data Security Manager (DSM) platform, along with key capabilities including External Key Manager.

Two AIP Publishing Journals Now Open Access Under Subscribe to Open Pilot

Retrieved on: 
Thursday, March 7, 2024

MELVILLE, N.Y., March 7, 2024 /PRNewswire/ -- Journal of Applied Physics and Physics of Plasmas, two of AIP Publishing's foremost scholarly publications, are now open access as part of a Subscribe to Open (S2O) pilot program.

Key Points: 
  • MELVILLE, N.Y., March 7, 2024 /PRNewswire/ -- Journal of Applied Physics and Physics of Plasmas, two of AIP Publishing's foremost scholarly publications, are now open access as part of a Subscribe to Open (S2O) pilot program.
  • The switch to open access (OA) is a result of our institutional subscribers renewing their subscriptions and supporting the S2O pilot program.
  • Announced in July 2023 , AIP Publishing's S2O pilot program is a demonstration of the publisher's commitment to equity, accessibility, and open science in scholarly publishing.
  • "When we announced our Subscribe to Open pilot last year, it was with the hope that these two journals would make the transition to open access, and we're excited that day has arrived," said Penelope Lewis, Chief Publishing Officer at AIP Publishing.

Rejuvenate Bio Announces Partnership with Leading Animal Health Company to Develop Gene Therapy for Canine Osteoarthritis

Retrieved on: 
Wednesday, February 14, 2024

Rejuvenate Bio today announced a partnership with a leading animal health company for the development and commercialization of its novel gene therapy technology for the treatment of canine osteoarthritis (OA), a complex chronic disease that affects dogs’ mobility and overall quality of life.

Key Points: 
  • Rejuvenate Bio today announced a partnership with a leading animal health company for the development and commercialization of its novel gene therapy technology for the treatment of canine osteoarthritis (OA), a complex chronic disease that affects dogs’ mobility and overall quality of life.
  • This agreement with the global company follows the agreement reached in 2022 with Phibro Animal Health and further validates the gene therapy technology developed by Rejuvenate Bio and their strategy to develop their breakthrough technology in both animal health and human health.
  • Canine osteoarthritis (OA) presents a significant challenge, being both painful and progressive, with a concerning prevalence rate.
  • “This partnership with a leading animal health company validates our technology and approach of utilizing gene therapy to treat chronic age-related diseases and ensures that this therapy will reach the dogs that need it.

Zoetis Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Tuesday, February 13, 2024

(NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2023 as well as provided full year guidance for 2024.

Key Points: 
  • (NYSE: ZTS) today reported its financial results for the fourth quarter and full year 2023 as well as provided full year guidance for 2024.
  • The company reported revenue of $2.2 billion for the fourth quarter of 2023, which was an increase of 8% compared with the fourth quarter of 2022, on both a reported and operational1 basis.
  • In the fourth quarter of 2023:
    Revenue in the U.S. segment was $1.2 billion, an increase of 9% compared with the fourth quarter of 2022.
  • Zoetis will host a webcast and conference call at 8:30 a.m. (ET) today, during which company executives will review fourth quarter and full year 2023 results, discuss financial guidance and respond to questions from financial analysts.

AeroBand's New Releases Shine at NAMM Show 2024, Garnering Rapid Popularity

Retrieved on: 
Thursday, February 8, 2024

For individuals with finger ailments and sensitivity, including children and the elderly, this breakthrough technology opens up musical possibilities for a wider audience.

Key Points: 
  • For individuals with finger ailments and sensitivity, including children and the elderly, this breakthrough technology opens up musical possibilities for a wider audience.
  • For beginners and those who had previously given up learning the guitar, AeroBand Guitar undoubtedly addresses the pain issue during practice.
  • During the Premier Guitar interview , the AeroBand team showcased a unique application designed specifically for the AeroBand Guitar.
  • At this year's NAMM Show, AeroBand takes the lead and showcases the highly anticipated product - PocketDrum 2 Plus.

Global Modified Polyphenylene Ether (mPPE) Market Review 2019-2023 and Forecast to 2029: Analysis of Major Growth Trends, R&D, Technology Updates, Statutory Regulations and Emerging Applications - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 31, 2024

The "Modified Polyphenylene Ether (mPPE) - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Modified Polyphenylene Ether (mPPE) - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.
  • The report reviews, analyzes and projects the global Modified Polyphenylene Ether (mPPE) market for the period 2019-2029 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2023 through 2029.
  • Automotive & Transportation and Electrical & Electronics industries are the leading consumers of mPPE worldwide with an estimated market share of around 29% each in 2023, followed by OA Equipment & Appliances estimated at 21%.
  • Global market share analysis for mPPE is provided based on the segmentation mentioned above; and current market size estimations and revenue projections given for the analysis period through 2029
    The study discusses major growth trends, R&D, technology updates, statutory regulations and emerging applications of mPPE that influence the market growth, wherever applicable
    Key business trends focusing on product innovations/developments, capacity expansions, M&As, JVs and other recent industry developments by the major players
    The market for end-use applications of mPPE analyzed in this report includes: